CommentNSAIDs and aspirin: notorious or FAMOUS?
References (13)
- et al.
Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial
Lancet
(2007) - et al.
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research & Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
Lancet
(2004) - et al.
Famotidine for the prevention of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs
N Engl J Med
(1996) - et al.
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
N Engl J Med
(2000) - et al.
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs
N Engl J Med
(1998) Safer NSAID strategies: consensus or contentious?
Rheumatology
(2008)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2009 Elsevier Ltd. All rights reserved.